Agilent Technologies, Inc. (A) Stock Price & Analysis
Agilent Technologies, Inc. (A) fell 0.84% to USD 138.57 as of July 25, 2026 at 01:12 UTC, according to Nexqual real-time market data.
A last closed at USD 139.74; the session ranged USD 138.02–140.5 on volume of 1,125,887 shares. Market capitalization is $39.14B, with a 52-week range of USD 108.35–160.27 (NYQ). Source: Nexqual, July 25, 2026 at 01:12 UTC.
Key Statistics (as of July 25, 2026 at 01:12 UTC)
| Price | USD 138.57 |
|---|---|
| Change | ▼ 0.84% (down) |
| Previous Close | USD 139.74 |
| Open | USD 140.46 |
| Day Range | USD 138.02 – 140.5 |
| 52-Week Range | USD 108.35 – 160.27 |
| Volume | 1,125,887 shares |
| Market Cap | $39.14B |
| Exchange | NYQ |
Technical Analysis (A)
Nexqual's technical model rates A "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 01:12 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 57.87 (neutral) |
| vs SMA50 | Above (USD 128.97) |
| MACD | 1.93 (positive) |
Analyst Ratings (A)
Wall Street analysts rate A "Buy" based on 19 analysts, with a mean price target of USD 159.32 (range USD 135–185), per Nexqual as of July 25, 2026 at 01:12 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 19 |
| Mean Target | USD 159.32 |
| High Target | USD 185 |
| Low Target | USD 135 |
| Buy / Hold / Sell | 17 / 4 / 0 |
Earnings (A)
| Next Earnings Date | 2026-08-26 |
|---|---|
| EPS Estimate | USD 1.49 |
| Revenue Estimate | $1.84B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-04-30 | USD 1.49 vs est 1.41 ▲ beat |
| 2026-01-31 | USD 1.36 vs est 1.37 ▼ miss |
| 2025-10-31 | USD 1.59 vs est 1.58 ▲ beat |
| 2025-07-31 | USD 1.37 vs est 1.37 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Financials & Fundamentals (A)
| Total Revenue | $7.23B |
|---|---|
| Revenue Growth (YoY) | +10.00% |
| Gross Margin | +52.64% |
| Operating Margin | +23.71% |
| Profit Margin | +19.55% |
| ROE | +21.33% |
| Debt / Equity | 49.73 |
| Current Ratio | 2.1 |
| Total Cash | $1.81B |
| Total Debt | $3.54B |
| Free Cash Flow | $930.63M |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Financial Health Score (A)
Nexqual rates Agilent Technologies, Inc.'s overall financial health "Solid" across five dimensions, as of July 25, 2026 at 01:12 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 53%, operating 24% |
| Balance Sheet | Strong — $1.81B cash vs $3.54B debt |
| Cash Flow | Solid — FCF $931M, 13% margin |
| Efficiency | Strong — ROE 21%, ROA 8.6% |
Ownership (A)
| Insider Ownership | +0.19% |
|---|---|
| Institutional Ownership | +94.28% |
| Shares Outstanding | 282.43M |
| Float | 281.47M |
| Short % of Float | +2.14% |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Leadership (A)
Agilent Technologies, Inc. is led by Padraig McDonnell (age 53), CEO, President & Director, per Nexqual as of July 25, 2026 at 01:12 UTC.
| CEO, President & Director | Padraig McDonnell (age 53) |
|---|---|
| Vice President of Finance | Rodney Gonsalves (age 59) |
| Senior VP & President of Agilent CrossLab Group | Angelica A. Riemann (age 54) |
| Senior VP and President of Life Sciences & Diagnostics Markets Group | Simon May (age 52) |
| Senior VP, CFO & Principal Financial Officer | Adam S. Elinoff (age 47) |
Major Backers & Investors (A)
Notable institutional backers of Agilent Technologies, Inc. include T. Rowe Price, Massachusetts Financial Services Co., Wellington Management, according to Nexqual as of July 25, 2026 at 01:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| T. Rowe Price | 4.69% |
| Massachusetts Financial Services Co. | 4.47% |
| Wellington Management | 2.57% |
| Morgan Stanley | 1.75% |
| Fidelity | 1.28% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 21.75% |
| BlackRock | 10.49% |
| State Street | 5.73% |
| Geode Capital | 2.66% |
| Deutsche Bank AG | 2.12% |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
From Agilent Technologies, Inc.'s Latest SEC 10-K Filing (filed 2025-12-22)
Key Strengths & Strategy (as disclosed to the SEC)
- Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
- The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets.
- The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems.
- This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KEYS | Keysight Technologies Inc. | USD 318.67 | ▼ 2.71% |
| HPQ | HP Inc. | USD 25.75 | ▲ 2.59% |
| ADI | Analog Devices, Inc. | USD 371.86 | ▼ 3.85% |
| TMO | Thermo Fisher Scientific Inc | USD 568.26 | ▲ 7.94% |
| DHR | Danaher Corporation | USD 191.5 | ▲ 6.9% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:12 UTC. This page is informational and not investment advice.